Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending November 5, 2022.
Investigators note that healthcare approaches may benefit from including patient-reported experiences of living with and being treated for fibromyalgia.
Investigators aimed to assess self-reported changes in physical activity during the COVID-19 pandemic.
"It may be important to identify genetic variants from a gout genome-wide association study (GWAS) rather than serum urate GWAS, in case these variants have an effect on gout independent of their effect on serum urate.”
The PRERA trial was the first real-world, non-interventional study to analyze radiographic progression in patients with RA or PsA treated with etanercept.
“Most thyroid diseases and rheumatoid arthritis are chronic diseases, and unfortunately, early signs of thyroid dysfunction are not specific and are often overshadowed by clinical manifestations of other diseases."